ALB and breast cancer: This study describes the synthesis, characterization, in vitro and preliminary in vivo assessment of novel nanoparticles, i.e., MAL-PTX2S@Pba, capable of in situ binding to circulating human serum albumin (HSA), and to exert combined photo- and chemo-toxicity on breast cancer cells.